To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

NWBO.OB $1.03 0.15 +14.6%
EXEL $3.80 0.30 +7.9%
SCLN $2.79 0.21 +7.5%
DCTH $6.25 0.38 +6.1%
ONTY $3.56 0.13 +3.7%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

CLDX $3.53 -1.25 -35.4%
RNN $1.20 -0.07 -5.8%
ONCY $3.17 -0.11 -3.5%
CYCC $1.50 -0.04 -2.7%
IMMU $2.95 -0.05 -1.7%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.





Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Next > | Last >>

Celgene Seeks to Stop Natco's Generic Revlimid

(Reuters) September 3, 2010 - Celgene Corp said it plans to file a complaint alleging infringement against India's Natco Pharma Ltd, which has submitted a request to the U.S. Food and Drug Administration for authorization to make and sell generic versions of Celgene's cancer drug Revlimid in the United States.
read article 



World of E Cigarettes: American Cancer Society Shuns E Cigarettes in Favor of the Real Thing

(Reuters) September 3, 2010 - The American Cancer Society continues to attack electronic cigarettes and falsely label them as dangerous and ineffective, while the number of people using the products is increasing by 20,000 to 30,000 a week.
read article 



China Cooking-Oil Maker Says Cancer-Causing Chemical in Product

(San Francisco Chronicle) September 2, 2010 - Jinhao Camellia Oil Corp., a Chinese maker of cooking oils, said about 42.5 tons of one of its products contained excessive amounts of a cancer-causing chemical.
read article 



Celsion Receives SBIR Grant To Expand Its Technology Platform

(Yahoo! Finance) September 2, 2010 - Celsion Corporation, a biotechnology drug development company, announced today that it has been awarded a competitive Phase I Small Business Innovation and Research (SBIR) grant from the National Institutes of Health (NIH), to support the proposal, "New Thermal Sensitive Carboplatin Liposomes for Cancer".
read article 



Vanderbilt-Ingram Cancer Center Opens Expanded Cancer Clinic

(Vanderbilt-Ingram) September 2, 2010 - Vanderbilt-Ingram Cancer Center has unveiled its newly expanded waiting area and additional clinic examination rooms for cancer patients and their families. The new, 10,000- square- foot space is located on the first floor of The Vanderbilt Clinic, across from the existing Cancer Center reception area.
read press release 



Patient Access and Reimbursement Challenges and Opportunities to be Addressed at AccessMED’s Patient Access Summit

(US Oncology) September 2, 2010 - Today’s healthcare reform environment brings new patient access and reimbursement implications to the pharmaceutical industry.
read press release 



Michael Douglas: 31 Days in the Life of a Throat Cancer Patient

(ABC News) September 3, 2010 - Another throat cancer patient tells of working his way through treatment, side-effects.
read article 



Medicare Cuts Threaten Specialist Services

(Utica Observer-Dispatch) September 1, 2010 - Hematology-Oncology Associates of Central New York stopped providing chemotherapy at its Rome office as of Sept. 1, a move necessitated by recent cuts in Medicare payments, officials said.
read article 



Oncolytics Stock Rises on Cancer Study Approval

(Reuters) September 2, 2010 - Oncolytics Biotech Inc stock climbed as much as 7 percent on Thursday after it said a mid-phase ovarian cancer study involving its proprietary formulation of the human reovirus was approved.
read article 



Seattle Genetics Achieves Milestone Under Antibody-Drug Conjugate Collaboration with Agensys, an Affiliate of Astellas

(Forbes) September 2, 2010 - Seattle Genetics, Inc. announced today that it has achieved a milestone under its antibody-drug conjugate (ADC) collaboration with Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc.
read article 



Prostate Cancer-Linked Chemical Prompts Alert on Baby-Food Cans

(Bloomberg Businessweek) September 1, 2010 - A chemical linked with prostate cancer and infertility should be eliminated from cans and plastics used to package food for babies and young children, a consumer advocacy group said.
read article 



President Obama Declares September 2010 'National Prostate Cancer Awareness Month'

(StreetInsider) September 1, 2010 - On August 31, President Barack Obama signed a presidential proclamation designating September 2010 as 'National Prostate Cancer Awareness Month," stating: "Until we find a cure for this disease, my Administration will continue promoting awareness of this illness and supporting prostate cancer research and treatment."
read article 



Susan G. Komen San Francisco Race for the Cure(R) Celebrates Its 20th Anniversary

(Yahoo! Finance) September 1, 2010 - More than 7,000 people of all ages are expected to gather on Sunday, September 26, 2010, along the Embarcadero for the 20th Annual Susan G. Komen San Francisco Race for the Cure®.
read article 



EmpowHER Offers FREE Resources and Support to Women Living With Ovarian Cancer

(Yahoo! Finance) September 1, 2010 - EmpowHER is offering free access to world-class health information as well as a supportive community for women diagnosed with ovarian cancer.
read article 



Agensys, an Affiliate of Astellas, Announces Initiation of Phase I Clinical Trial of AGS-16M8F for Renal Cancer

(Yahoo! Finance) September 1, 2010 - Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today announced that they have initiated a Phase I clinical trial of AGS-16M8F an antibody-drug conjugate (ADC) that is being developed for the treatment of metastatic renal cancer.
read article 



PDL Says Gets August Royalty Payment from Genentech

(Reuters) September 1, 2010 - PDL BioPharma Inc said it received all royalty payments due in August from licensee Genentech, relieving concerns that it would not see some of the money after the biotech giant said its products did not infringe PDL's patents.
read article 



BSD Medical Tissue Device Safety Compliant, Shrs Jump

(Reuters) September 1, 2010 - BSD Medical Corp said it received certification that its device to destroy diseased tissue complies with an international standard of medical device safety, sending its shares up 13 percent.
read article 



St. Jude Children's Research Hospital Doctors and Scientists Team up to Fight Childhood Cancer

(St. Jude) September 1, 2010 - Survival rates overall for childhood cancer are almost 80 percent—a marked advance against a disease that was curable in only a small fraction of children 50 years ago.
read press release 



MCW Appoints Cancer Center Director

(Business Journal of Milwaukee) August 31, 2010 - An internationally recognized lung cancer researcher, Dr. Ming You, has been named director of The Medical College of Wisconsin Cancer Center in Wauwatosa.
read article 



Radiation Oncologist Brian Kavanagh Named to APC Advisory Panel

(ASTRO) September 1, 2010 - The American Society for Radiation Oncology (ASTRO) is pleased to announce that the Centers for Medicare and Medicaid Services (CMS) has named ASTRO committee member Brian D. Kavanagh, M.D., M.P.H., to serve a four-year-term on the Advisory Panel on Ambulatory Payment Classification (APC) Groups.
read press release 



RPCI Faculty Member Named to Federal Panel on Breast Cancer Research

(RPCI) September 1, 2010 - Christine B. Ambrosone, PhD, Chair of the Department of Cancer Prevention and Control and Professor of Oncology at Roswell Park Cancer Institute (RPCI), has been named to a new advisory committee that will develop a strategic federal research agenda on environmental and genetic factors related to breast cancer.
read press release 



Opinion: A Dying Patient Is Not a Battlefield

(CNN) August 31, 2010 - The patient, in his late 70s, had survived prostate cancer and had a new diagnosis of leukemia. A few days before, he'd been healthy and fine, but now his white blood cell count was so high that it was clogging his circulatory system, making it hard for him to breathe.
read article 



Letters: Comfort at Life’s End (1 Letter)

(New York Times) August 30, 2010 - Re “Frank Talk About Care at Life’s End” (Personal Health, Aug. 24): End-of-life and palliative care present growing challenges for doctors as well as patients. First, many patients are living much longer with incurable cancers, so it becomes difficult to accept that no further options are available.
read article (free registration required) 



21 Drugs Facing FDA Approval Decisions

(TheStreet) August 31, 2010 - The fall will be a very busy time for U.S. drug approvals...Avastin for metastatic breast cancer...Prolia for bone complications in cancer patients...Ipilimumab for melanoma...
read article 



Avastin and Metastatic Breast Cancer: When Science-Based Medicine Collides with FDA Regulation

(Science-Based Medicine) August 30, 2010 - One of the most frustrating aspects of taking care of cancer patients is that in general, with only a few specific exceptions, we do not have good curative therapies for patients with stage IV cancer, particularly solid tumors.
read article